Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns

Alzheimer’s disease (AD) is the most prevalent type of dementia and its pathology is characterized by deposition of extracellular β-amyloid plaques, intracellular neurofibrillary tangles, and extensive neuron loss. While only a few familial AD cases are due to mutations in three causative genes (APP...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiwei Zhang, Bin Jiao, Miaojin Zhou, Tao Zhou, Lu Shen
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2016/7828049
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561084577349632
author Weiwei Zhang
Bin Jiao
Miaojin Zhou
Tao Zhou
Lu Shen
author_facet Weiwei Zhang
Bin Jiao
Miaojin Zhou
Tao Zhou
Lu Shen
author_sort Weiwei Zhang
collection DOAJ
description Alzheimer’s disease (AD) is the most prevalent type of dementia and its pathology is characterized by deposition of extracellular β-amyloid plaques, intracellular neurofibrillary tangles, and extensive neuron loss. While only a few familial AD cases are due to mutations in three causative genes (APP, PSEN1, and PSEN2), the ultimate cause behind the rest of the cases, called sporadic AD, remains unknown. Current animal and cellular models of human AD, which are based on the Aβ and tau hypotheses only, partially resemble the familial AD. As a result, there is a pressing need for the development of new models providing insights into the pathological mechanisms of AD and for the discovery of ways to treat or delay the onset of the disease. Recent preclinical research suggests that stem cells can be used to model AD. Indeed, human induced pluripotent stem cells can be differentiated into disease-relevant cell types that recapitulate the unique genome of a sporadic AD patient or family member. In this review, we will first summarize the current research findings on the genetic and pathological mechanisms of AD. We will then highlight the existing induced pluripotent stem cell models of AD and, lastly, discuss the potential clinical applications in this field.
format Article
id doaj-art-56d81803e1e741aeb5a6479ce94dd67c
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-56d81803e1e741aeb5a6479ce94dd67c2025-02-03T01:25:56ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/78280497828049Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future ConcernsWeiwei Zhang0Bin Jiao1Miaojin Zhou2Tao Zhou3Lu Shen4Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, ChinaDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, ChinaState Key Laboratory of Medical Genetics, Central South University, Changsha, Hunan 410008, ChinaState Key Laboratory of Medical Genetics, Central South University, Changsha, Hunan 410008, ChinaDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, ChinaAlzheimer’s disease (AD) is the most prevalent type of dementia and its pathology is characterized by deposition of extracellular β-amyloid plaques, intracellular neurofibrillary tangles, and extensive neuron loss. While only a few familial AD cases are due to mutations in three causative genes (APP, PSEN1, and PSEN2), the ultimate cause behind the rest of the cases, called sporadic AD, remains unknown. Current animal and cellular models of human AD, which are based on the Aβ and tau hypotheses only, partially resemble the familial AD. As a result, there is a pressing need for the development of new models providing insights into the pathological mechanisms of AD and for the discovery of ways to treat or delay the onset of the disease. Recent preclinical research suggests that stem cells can be used to model AD. Indeed, human induced pluripotent stem cells can be differentiated into disease-relevant cell types that recapitulate the unique genome of a sporadic AD patient or family member. In this review, we will first summarize the current research findings on the genetic and pathological mechanisms of AD. We will then highlight the existing induced pluripotent stem cell models of AD and, lastly, discuss the potential clinical applications in this field.http://dx.doi.org/10.1155/2016/7828049
spellingShingle Weiwei Zhang
Bin Jiao
Miaojin Zhou
Tao Zhou
Lu Shen
Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
Stem Cells International
title Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
title_full Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
title_fullStr Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
title_full_unstemmed Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
title_short Modeling Alzheimer’s Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns
title_sort modeling alzheimer s disease with induced pluripotent stem cells current challenges and future concerns
url http://dx.doi.org/10.1155/2016/7828049
work_keys_str_mv AT weiweizhang modelingalzheimersdiseasewithinducedpluripotentstemcellscurrentchallengesandfutureconcerns
AT binjiao modelingalzheimersdiseasewithinducedpluripotentstemcellscurrentchallengesandfutureconcerns
AT miaojinzhou modelingalzheimersdiseasewithinducedpluripotentstemcellscurrentchallengesandfutureconcerns
AT taozhou modelingalzheimersdiseasewithinducedpluripotentstemcellscurrentchallengesandfutureconcerns
AT lushen modelingalzheimersdiseasewithinducedpluripotentstemcellscurrentchallengesandfutureconcerns